Federal Register Notice: FDA has determined that Travatan (travoprost ophthalmic solution), 0.004%, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for travoprost ophthalmic solution, 0.004%, if all other legal and regulatory requirements are met. To view this notice, click here.
